Brizzi, A.; Trezza, A.; Spiga, O.; Maramai, S.; Scorzelli, F.; Saponara, S.; Fusi, F.
2-Hydroxy-5-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl (E)-3-(4-hydroxy-3-methoxyphenyl)acrylate: Synthesis, In Silico Analysis and In Vitro Pharmacological Evaluation. Molbank 2021, 2021, M1258.
https://doi.org/10.3390/M1258
AMA Style
Brizzi A, Trezza A, Spiga O, Maramai S, Scorzelli F, Saponara S, Fusi F.
2-Hydroxy-5-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl (E)-3-(4-hydroxy-3-methoxyphenyl)acrylate: Synthesis, In Silico Analysis and In Vitro Pharmacological Evaluation. Molbank. 2021; 2021(3):M1258.
https://doi.org/10.3390/M1258
Chicago/Turabian Style
Brizzi, Antonella, Alfonso Trezza, Ottavia Spiga, Samuele Maramai, Francesco Scorzelli, Simona Saponara, and Fabio Fusi.
2021. "2-Hydroxy-5-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl (E)-3-(4-hydroxy-3-methoxyphenyl)acrylate: Synthesis, In Silico Analysis and In Vitro Pharmacological Evaluation" Molbank 2021, no. 3: M1258.
https://doi.org/10.3390/M1258
APA Style
Brizzi, A., Trezza, A., Spiga, O., Maramai, S., Scorzelli, F., Saponara, S., & Fusi, F.
(2021). 2-Hydroxy-5-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl (E)-3-(4-hydroxy-3-methoxyphenyl)acrylate: Synthesis, In Silico Analysis and In Vitro Pharmacological Evaluation. Molbank, 2021(3), M1258.
https://doi.org/10.3390/M1258